| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |